Helge Sander: "Fler kvinnor behövs"

- Det är något fel när det ena könet i stort sett väljer bort en karriär som forskare, säger Danmarks forskningsminister. Idag håller han rundabordssamtal för att diskutera varför kvinnliga forskare missgynnas. Han välkomnar alla lösningar, utom en.

Roche sänker budet på Genentech

I juli ifjol var budet 89 dollar per aktie. Då sa Genentechs styrelse nej tack. Nu meddelar läkemedelsjätten att man sänker budet och vänder sig direkt till småägarna.

Grönt ljus för Getinges bolagsköp

Medicinteknikföretaget Getinge har fått godkännande från den amerikanska konkurrensmyndigheten Federal Trade Commission, FTC för köpet av bolaget Datascope Corp. Efter klartecken från amerikanska myndigheter kan den segdragna affären nu slutföras.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Go ahead for leg wound study

Tripep starts a phase II-study of their wound healing joint venture project.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

New study of toxins and heart disease

Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study will try to evaluate this, and one thousand people are to be included.

Biotage is regrouping

The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.

Vitamin D is mental health aid

Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

EU says yes to Roche drug

EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.

Vattenfall is firing with biomass

Vattenfall will provide Denmark with electricity by means of biomass.

Swedish nanotech crosses the Atlantic

Genovis signs distribution agreement Finnzymes in US.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

Finnish Innovation Fund gets new leader

The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

LEO Pharma - International Clinical Trial Manager

Crafoord Prize to an American and two Japanese

Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Norwegian describes scrapie gene

Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.